RBC Capital Reiterates Outperform on Eli Lilly, Maintains $1500 Price Target

Benzinga Newsdesk www.benzinga.com Negative 88.2%

Neg 88.2% Neu 0% Pos 0%

RBC Capital analyst Trung Huynh reiterates Eli Lilly (NYSE:LLY) with a Outperform and maintains $1500 price target.

Comments

No comments yet. Be the first!